Compare Stocks → Gold Mania (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:SENS Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeSENSSenseonics$0.50-1.9%$0.53$0.38▼$1.05$268.01M0.912.47 million shs1.50 million shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceSENSSenseonics-2.37%+21.67%-2.05%-7.36%-13.95%The asset beating inflation by 4x (Ad)"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the detailsMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationSENSSenseonics0.8316 of 5 stars3.00.00.00.02.40.00.6Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceSENSSenseonics2.00Hold$1.25147.57% UpsideCurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookSENSSenseonics$22.39M11.97N/AN/A$0.07 per share7.21Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateSENSSenseonics-$60.39M-$0.11N/AN/AN/A-270.13%-146.90%-49.81%N/ALatest SENS, IQAI, TRLS, and INHC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/29/2024Q4 2023SENSSenseonics-$0.04-$0.03+$0.01-$0.03$7.62 million$8.00 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthSENSSenseonicsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioSENSSenseonics1.157.537.03OwnershipInstitutional OwnershipCompanyInstitutional OwnershipSENSSenseonics12.36%Insider OwnershipCompanyInsider OwnershipSENSSenseonics3.90%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableSENSSenseonics132530.82 million510.12 millionN/ASENS, IQAI, TRLS, and INHC HeadlinesSourceHeadlineSenseonics (NYSE:SENS) Coverage Initiated at StockNews.commarketbeat.com - May 4 at 12:28 AMSenseonics Holdings, Inc. to Participate in Upcoming Conferencesbusinesswire.com - May 2 at 8:05 AMAscensia receives iCGM designation for Eversensehmenews.com - May 1 at 2:47 PMBird flu testing shows more dairy products are safe, US FDA saysfinance.yahoo.com - May 1 at 1:19 PMFDA Allows Implantable CGM to Integrate With Insulin Pumpsmedscape.com - May 1 at 12:31 PMSenseonics gets FDA clearance to pair CGM implant with insulin pumpsmedtechdive.com - May 1 at 12:31 PMEversense CGM system receives iCGM designation by FDAmedicalplasticsnews.com - May 1 at 9:47 AMSenseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Timefinance.yahoo.com - April 30 at 7:02 PMSenseonics wins integrated CGM designation from FDA, can work with insulin pumpsmassdevice.com - April 30 at 2:08 PMEversense® CGM System Receives iCGM Designation by the US FDAbusinesswire.com - April 30 at 7:00 AMEversense® CGM System Receives iCGM Designation by the US FDAbusinesswire.com - April 30 at 7:00 AMContinuous Glucose Monitoring Market to hit USD 20 Bn by 2032, says Global Market Insights Inc.finance.yahoo.com - April 29 at 8:07 AMSenseonics (NYSE:SENS) Trading Up 7.8%americanbankingnews.com - April 24 at 3:00 AMArtificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies 2024finance.yahoo.com - April 4 at 8:15 AMComprehensive Market Analysis Reveals Significant Insights into the Insulin Pumps and Continuous Glucose Monitors Market Through 2033finance.yahoo.com - April 3 at 3:17 PMProfessional Wearable Medical Device Market: Driving Innovations in Healthcare Technologypharmiweb.com - March 15 at 9:00 AMAscensia, Senseonics announce new CGM cost savingsmassdevice.com - March 12 at 3:02 PMExperts Offer CGM Tips for Type 1 Diabetesmedscape.com - March 12 at 7:47 AMSAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMSprnewswire.com - March 12 at 7:00 AMHand Held Glucose Meter Market – Navigating Trends and Transformations in Glucose Monitoringpharmiweb.com - March 11 at 5:22 AMSenseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetesbusinesswire.com - March 8 at 8:05 AMSenseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conferencebusinesswire.com - March 6 at 8:05 AMSenseonics Holdings, Inc. (AMEX:SENS) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 2 at 9:13 AMSenseonics slips amid concerns over demand for Eversensemsn.com - March 1 at 7:41 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Stocks Leading the U.S. Agriculture ComebackApril 26, 2024 10:10 AMView 3 Stocks Leading the U.S. Agriculture ComebackHow to Use Put Debit Spreads to Profit From Falling Stocks April 26, 2024 9:30 AMView How to Use Put Debit Spreads to Profit From Falling Stocks Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 monthsLockheed Martin Stock Aims for a Fresh All-Time HighApril 23, 2024 9:59 AMView Lockheed Martin Stock Aims for a Fresh All-Time HighD.R. Horton Stock Has Tailwinds To Drive it HigherApril 18, 2024 8:30 AMView D.R. Horton Stock Has Tailwinds To Drive it HigherAll Headlines Company DescriptionsSenseonicsNYSE:SENSSenseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
